Biotech ETF Overview

With 14 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $12.41B. The average expense ratio is 0.73%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $6.34B in assets. In the last trailing year, the best performing Biotech ETF was the GNOM at --. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

ETF Strategist Corner

Alpha's Not Dead

Like punk rock, alpha is very much alive. 

Podcasts

ETF Prime Podcast: Companies Targeting The Virus

Biotech expert Brad Loncar goes in-depth on coronavirus treatments and vaccines.

Features and News

Leveraged ETF Closures Piling Up

Since the market volatility began, almost 30 leveraged and inverse products have shut up shop. But why now?

Features and News

The Love & Hate Of Biotech ETFs

The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.

ETF Report

Sectors In Review: January 2020

Sector ETFs had a great month, with most seeing positive returns.

ETF Report

 Sectors In Review: December 2019

A few sector ETFs faltered during the month

ETF Report

 Sectors In Review: November 2019

Sector ETFs did fairly well during the month, with a few exceptions

ETF Report

Sectors In Review: September 2019

Sector ETFs recorded largely positive performance during July.

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.